These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19860782)

  • 1. Intravitreal bevacizumab for choroidal neovascularization secondary to inflammation.
    Wolf A; Thurau S; Kook D; Hoeing A; Priglinger S; Kampik A; Haritoglou C
    Acta Ophthalmol; 2010 Nov; 88(7):e295-6. PubMed ID: 19860782
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy.
    Mavrakanas N; Mendrinos E; Tabatabay C; Pournaras CJ
    Acta Ophthalmol; 2010 Mar; 88(2):e54-5. PubMed ID: 19489761
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
    Guthoff R; Goebel W
    Acta Ophthalmol; 2009 Sep; 87(6):688-90. PubMed ID: 18631326
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab.
    Yoon YH; Kim JG; Chung H; Lee SY
    Acta Ophthalmol; 2009 Sep; 87(6):685-7. PubMed ID: 18705680
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture.
    Chanana B; Azad RV; Kumar N
    Eye (Lond); 2009 Nov; 23(11):2125-6. PubMed ID: 19169235
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for idiopathic choroidal neovascularization.
    Cakir M; Cekiç O; Yilmaz OF
    J AAPOS; 2009 Jun; 13(3):296-8. PubMed ID: 19285890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal neovascularization associated with West Nile virus chorioretinitis.
    Seth RK; Stoessel KM; Adelman RA
    Semin Ophthalmol; 2007; 22(2):81-4. PubMed ID: 17564926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.
    Song WK; Koh HJ; Kwon OW; Byeon SH; Lee SC
    Acta Ophthalmol; 2009 Feb; 87(1):100-1. PubMed ID: 19178391
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravitreal bevacizumab for uveitic choroidal neovascularization.
    Doctor PP; Bhat P; Sayed R; Foster CS
    Ocul Immunol Inflamm; 2009; 17(2):118-26. PubMed ID: 19412874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.
    Jonas JB; Tao Y; Rensch F
    Acta Ophthalmol; 2011 Feb; 89(1):e105-7. PubMed ID: 20064119
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease.
    Cakir M; Cekiç O; Yilmaz OF
    J AAPOS; 2009 Feb; 13(1):94-6. PubMed ID: 19101187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.
    Tewari A; Dhalla MS; Apte RS
    Retina; 2006; 26(9):1093-4. PubMed ID: 17151505
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab.
    Malik A; Sood S; Narang S
    Int Ophthalmol; 2010 Aug; 30(4):425-8. PubMed ID: 20049508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.
    Schadlu R; Blinder KJ; Shah GK; Holekamp NM; Thomas MA; Grand MG; Engelbrecht NE; Apte RS; Joseph DP; Prasad AG; Smith BT; Sheybani A
    Am J Ophthalmol; 2008 May; 145(5):875-8. PubMed ID: 18321466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.
    Spaide RF
    Am J Ophthalmol; 2009 Jul; 148(1):1-3. PubMed ID: 19540983
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy.
    Pai SA; Shetty R
    Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250
    [No Abstract]   [Full Text] [Related]  

  • 19. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
    Teixeira A; Moraes N; Farah ME; Bonomo PP
    Acta Ophthalmol Scand; 2006 Dec; 84(6):835-6. PubMed ID: 17083556
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.